There are a lot of reasons to set up shop in Germany, if you’ve got a medical biotechnology business. It’s the center of the sector in Europe and at the heart of the industry worldwide, as our new video discusses.
In 2018, 36 of the 65 newly approved medications in Germany were biopharmaceuticals – an unprecedented fifty-eight percent.
Israel’s Kidod Science & Technologies has joined the eastern German city’s Health + IT Campus.
As Europe’s largest medical biotech market, Germany continues to attract foreign investment thanks to its many established companies and dynamic start-up sector. Gradian Diagnostics’ recent acquisition of Molzym is a fine example of international matchmaking, facilitated by Germany Trade & Invest.
German biotech continues to grow, representing an opportunity for foreign capital.
Germany is Europe’s number one healthcare market by volume: Patients, manufacturers and providers power a life science industry composed of thriving medical technology, pharmaceuticals, medical biotechnology, and digital health sectors.
Germany’s single-cell biotechnology sector is transforming cancer treatments by shining a light on the genetic activity of individual cells. It’s also advancing our understanding of how our immune defences respond to Covid-19.
Throughout 2021, this website featured more than 330 articles and videos about Germany as a business and high-tech location. Below is a list so that you can catch up on anything you might have missed.
Industrial electromobility picks up the pace in Saxony-Anhalt.
Over the past decade, healthtech startups in the Bavarian capital have taken in just under EUR 968 million in financing – that’s according to information compiled by the website Munich Startup in its Data & Insights Dashboard.
If you are not happy with the results below please do another search
